For: | Liu XR, Tian M. Glucocorticoids combined with tofacitinib in the treatment of Castleman's disease: A case report. World J Clin Cases 2022; 10(29): 10794-10802 [PMID: 36312499 DOI: 10.12998/wjcc.v10.i29.10794] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i29/10794.htm |
Number | Citing Articles |
1 |
Takuya Kakutani, Riko Kamada, Yotaro Tamai. Pathophysiology, Treatment, and Prognosis of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome: A Review. Current Issues in Molecular Biology 2024; 46(10): 11255 doi: 10.3390/cimb46100668
|
2 |
Mariusz Sikora, Nel Dąbrowska-Leonik, Piotr Buda, Beata Wolska-Kuśnierz, Karina Jahnz-Różyk, Małgorzata Pac, Ewa Więsik-Szewczyk. Castleman Disease—Still More Questions than Answers: A Case Report and Review of the Literature. Journal of Clinical Medicine 2025; 14(8): 2799 doi: 10.3390/jcm14082799
|
3 |
雨晴 李. Analysis of the Diagnosis and Treatment of Multicenter Castleman’s Disease with Ascites as the Main Manifestation. Advances in Clinical Medicine 2024; 14(09): 779 doi: 10.12677/acm.2024.1492529
|